Akamai Technologies, Inc. (NASDAQ:AKAM) will release earnings results for its fourth quarter, after the closing bell on Thursday, Feb. 19.Analysts expect the Cambridge, Massachusetts-based company to report quarterly earnings at $1.75 per share, up from $1.66 per share in the year-ago period. The consensus estimate for Akamai's quarterly revenue is $1.08 billion, versus $1.02 billion a year earlier, according to data from Benzinga Pro.On Dec. 17, Akamai partnered with Visa Inc. (NYSE:V) to enhance identity ...

Earnings Report - Akamai Technologies, Inc. is set to release its fourth-quarter earnings results on February 19, with analysts expecting earnings of $1.75 per share, an increase from $1.66 per share in the same period last year [1] - The consensus estimate for quarterly revenue is $1.08 billion, compared to $1.02 billion a year earlier [1] Partnership and Stock Performance - On December 17, Akamai partnered with Visa Inc. to enhance identity verification, user recognition, and security for agentic commerce [2] - Following this partnership, Akamai's shares increased by 0.8%, closing at $109.31 [2]

President Donald Trump claimed on Wednesday that his administration's aggressive tariff policies have sparked a "staggering" 78% reduction in the U.S. trade deficit, vowing the nation will soon achieve its first trade surplus in decades.A Milestone In Trade Policy?In an all-caps post on Truth Social, the President lauded the impact of his global “reciprocal tariffs,” which targeted over 100 countries starting in April 2025.Trump attributed the contraction directly to these duties, stating, "The United State ...

Carvana Co. (NYSE:CVNA) shares slipped in premarket trading on Thursday as investors weighed fresh earnings details and cost pressures.The online used-vehicle retailer delivered stronger revenue than expected, yet mounting operational expenses and short-seller scrutiny shaped early sentiment around the stock.Quarterly PerformanceCarvana posted fourth-quarter revenue of nearly $5.6 billion, surpassing analyst projections that tracked closer to $5.26 billion. The company also disclosed earnings of $4.22 per s ...

Two long and one inverse fund continue Tradr's tradition of launching first-to-market strategiesNEW YORK, Feb. 19, 2026 /PRNewswire/ -- Tradr ETFs, a provider of ETFs designed for sophisticated investors and professional traders, today launched three new leveraged ETFs on single stocks. The Cboe-listed funds seek to deliver either two times the inverse (-200%) or two times long (200%) the daily performance of a specific underlying stock. All three ETFs are first-to-market strategies.The following ETFs are e ...

Zinger Key Point:MTX240's mechanistic novelty may give it a long-awaited edge in treatments for gastrointestinal stromal tumors (GIST)Biodexa Pharmaceuticals PLC (NASDAQ:BDRX) , a clinical-stage biopharmaceutical company developing a pipeline of innovative products for the treatment of rare diseases with an increasing focus on products to treat or prevent gastrointestinal cancers, has added a new phase 1-ready candidate to its portfolio, this time to target gastrointestinal stromal tumors, or GIST. MTX240's ...

The U.S. State Department is reportedly developing an online portal to provide access to content banned by European and other governments.The portal aims to bypass censorship by granting access to restricted content, including purported hate speech and terrorist propaganda. The site, set to launch at “freedom.gov,” is led by Undersecretary for Public Diplomacy Sarah Rogers, Reuters reported on Thursday.Officials had explored adding a virtual private network (VPN) feature to make users' traffic appear as if ...

Core Viewpoint - The health care sector has several oversold stocks that present potential buying opportunities for undervalued companies [1]. Group 1: Oversold Stocks - The Relative Strength Index (RSI) is a momentum indicator that helps traders assess stock performance, with an RSI below 30 indicating that a stock is typically considered oversold [1]. - A list of major oversold stocks in the health care sector includes companies with an RSI near or below 30 [2]. Group 2: Company Specifics - Schrodinger Inc (NASDAQ:SDGR) has an RSI value of 29.9, with its stock price falling approximately 28% over the past month, reaching a 52-week low of $11.15 [3]. - On February 18, Schrodinger reported inducement grants under Nasdaq Listing Rule 5635(c)(4) [3]. - Schrodinger's shares rose by 1.6% to close at $11.81 on Wednesday, with an Edge Stock Rating momentum score of 2.78 [3].

The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.The RSI is a momentum indicator, which compares a stock’s strength on days when prices go up to its strength on days when prices go down. When compared to a stock’s price action, it can give traders a better sense of how a stock may perform in the short term. An asset is typically considered oversold when the RSI is below 30, according to Benzinga Pro.Here's the latest list of major oversold players ...

Core Insights - The anticipated copper supply crunch is more related to downstream smelting and refining capacity rather than raw copper supply from mines [1][4] - The U.S. can meet 146% of its domestic copper demand through a combination of mine output, scrap, and overseas supply, contrasting with China's reliance on imports for 60% of its copper needs [2] - Rising copper prices, which have increased approximately 40% since October, are driven by supply disruptions and strong future demand linked to electrification and clean-energy technologies [3][5] Industry Analysis - Expanding refining and scrap-processing capacity is deemed more effective for improving supply security than acquiring new mines abroad, challenging current policy efforts focused on upstream supply [4] - The rising price of copper is becoming a significant profit driver for diversified mining companies, especially as iron-ore markets weaken [5]